29 Results

People

  1. Hsu
    Hsu
  2. Barker
    Barker
  3. Young
    Young
  4. Jakubowski
    Jakubowski
  5. Papadopoulos
    Papadopoulos
  6. Perales
    Perales
  7. O'Reilly
    O'Reilly
  8. Castro-Malaspina
    Castro-Malaspina
  9. Scaradavou
    Scaradavou
  10. Giralt
    Giralt

Groups

  1. Bone Marrow Transplant (29)
  2. Center for Hematologic Malignancies (29)
  3. Department of Medicine (29)
  4. GSK Faculty (29)
  5. Hematologic Malignancies Research (29)
  6. Hematologic Malignancies, Division of (29)
  7. Human Oncology and Pathogenesis Program (27)
  8. Tow Center for Developmental Oncology (TCDO) (27)
  9. Sloan Kettering Institute Faculty (24)
  10. Immunology Program Faculty (23)
  1. "Hematologic Malignancies Research"
  2. "Juliet Barker"
Formats
  1. Meeting Abstract (16)
  2. Journal Article (13)
Groups
  1. Bone Marrow Transplant (29)
  2. Center for Hematologic Malignancies (29)
  3. Department of Medicine (29)
  4. GSK Faculty (29)
  5. Hematologic Malignancies Research (29)
  6. Hematologic Malignancies, Division of (29)

More Groups

People
  1. Juliet Barker (29)
  2. Katharine Hsu (27)
  3. James Young (20)
  4. Ann Jakubowski (19)
  5. Esperanza Papadopoulos (19)
  6. Miguel-Angel Perales (19)

More People

Years
  1. 2021 (3)
  2. 2020 (3)
  3. 2019 (1)
  4. 2018 (2)
  5. 2017 (3)
  6. 2016 (1)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (13)
  2. Blood (7)
  3. Bone Marrow Transplantation (2)
  4. Leukemia (2)
  5. Blood Advances (1)
  6. Journal of Clinical Investigation (1)

More Publications

Publishers
  1. Elsevier Inc. (13)
  2. American Society of Hematology (8)
  3. Nature Publishing Group (5)
  4. Amer Assoc Advancement Science (1)
  5. American Society for Clinical Investigation (1)
  6. The American Association of Immunologists, Inc (1)

Results (29)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A chemotherapy-only regimen of busulfan, melphalan, and fludarabine, and rabbit antithymocyte globulin followed by allogeneic T-cell depleted hematopoietic stem cell transplantations for the treatment of myeloid malignancies
    Journal Article

    Spitzer, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Fuller, K.; Hilden, P. D.; Young, J. W.; Barker, J. N.; Koehne, G.; Perales, M. A.; Hsu, K. C.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Selection and purification of CD34+ cells from cryopreserved cord blood units using CliniMACS Plus and CliniMACS Prodigy
    Meeting Abstract

    Wang, X. Y.; Stefanski, J.; Hack, A.; He, Q.; Boyle, R.; Barker, J.; Scandura, J.; Rafii, S.; Sadelain, M.; Riviere, I.
    Molecular Therapy (2017)

    Fulltext@MSK | Save
  • Low dose unfractionated heparin (UFH) prophylaxis is a feasible strategy for the prevention of hepatic sinusoidal obstruction syndrome (SOS) after myeloablative adult allogeneic hematopoietic stem cell transplantation (HSCT)
    Meeting Abstract

    Bhatt, V.; Palazzo, M.; Kilroy, K.; Hilden, P.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D. J.; Dahi, P.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Low dose unfractionated heparin (UFH) prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome (SOS) in adult allogeneic stem cell transplant (HSCT) recipients
    Meeting Abstract

    Bhatt, V.; Palazzo, M.; Kilroy, K.; Hilden, P.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H. R.; Chung, D. J.; Dahi, P. B.; Hsu, K. C.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • High disease-free survival with enhanced protection against relapse after double-unit cord blood transplantation when compared with T cell-depleted unrelated donor transplantation in patients with acute leukemia and chronic myelogenous leukemia
    Journal Article

    Ponce, D. M.; Hilden, P.; Devlin, S. M.; Maloy, M.; Lubin, M.; Castro-Malaspina, H.; Dahi, P.; Hsu, K.; Jakubowski, A. A.; Kernan, N. A.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Barker, J.; Castro-Malaspina, H.; Curran, K.; Giralt, S.; Hasan, A.; Heller, G.; Hsu, K.; Jakubowski, A.; more...
    Bone Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia
    Journal Article

    Pegram, H. J.; Purdon, T. J.; van Leeuwen, D. G.; Curran, K. J.; Giralt, S. A.; Barker, J. N.; Brentjens, R. J.
    Leukemia (2015)

    Fulltext@MSK | Save
  • KIR and HLA genotypes have no identifiable role in single-unit dominance following double-unit umbilical cord blood transplantation
    Journal Article

    Tarek, N.; Gallagher, M. M.; Chou, J. F.; Lubin, M. N.; Heller, G.; Barker, J. N.; Hsu, K. C.
    Bone Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation
    Journal Article

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S. M.; Lubin, M.; Giralt, S.; Goldberg, J. D.; Hanash, A.; Hsu, K.; Jenq, R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation
    Meeting Abstract

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M.; Evans, K.; Prockop, S. E.; Scaradavou, A.; Kernan, N.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save